Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| USBC, Inc.USBC · Entity 6370 | Chief Operating Officer | October 07, 2025 | October 09, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
USBC, Inc.
Report date October 07, 2025 · Filed October 09, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Option to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $2.45 · Expires 2035-08-06 | Direct | 0 |
Reported balance
After 2025-10-07 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-10-07 · Disposition to issuer · Disposed 7,140,000 · Balance 0 F1: The transactions reported involved the repricing of outstanding stock options to purchase 7,140,000 shares of common stock of USBC, Inc. (the "Company") pursuant to the Amended and Restated USBC, Inc. 2021 Equity Incentive Plan (the "Amended and Restated 2021 Plan"), initially granted on August 6, 2025 (the "Grant Date"). The option will vest as to 25% of the shares covered by the option on the one-year anniversary of the Grant Date and in quarterly installments thereafter over the next three years. |
| Option to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $1.10 · Expires 2035-10-07 | Direct | 7,140,000 |
Reported balance
After 2025-10-07 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-10-07 · Grant · Acquired 7,140,000 · Balance 7,140,000 F2: On October 7, 2025, in accordance with the terms of the Amended and Restated 2021 Plan, the Board of Directors the Company approved a repricing of outstanding stock options granted on August 6, 2025. The exercise price of each repriced option was reduced from $2.45 to $1.10 per share. |
| Option to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $1.10 · Expires 2035-10-07 | Direct | 15,000,000 |
Reported balance
After 2025-10-07 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2025-10-07 · Grant · Acquired 7,860,000 · Balance 15,000,000 F3: On October 7, 2025, the Reporting Person was granted an option to purchase 7,860,000 shares of the Issuer's common stock pursuant to the Amended and Restated 2021 Plan. The option will vest as to 25% of the shares covered by the option on the one-year anniversary of the Grant Date and in quarterly installments thereafter over the next three years. |
Filing footnotes · ownership attribution and instrument terms
F1: The transactions reported involved the repricing of outstanding stock options to purchase 7,140,000 shares of common stock of USBC, Inc. (the "Company") pursuant to the Amended and Restated USBC, Inc. 2021 Equity Incentive Plan (the "Amended and Restated 2021 Plan"), initially granted on August 6, 2025 (the "Grant Date"). The option will vest as to 25% of the shares covered by the option on the one-year anniversary of the Grant Date and in quarterly installments thereafter over the next three years.
F2: On October 7, 2025, in accordance with the terms of the Amended and Restated 2021 Plan, the Board of Directors the Company approved a repricing of outstanding stock options granted on August 6, 2025. The exercise price of each repriced option was reduced from $2.45 to $1.10 per share.
F3: On October 7, 2025, the Reporting Person was granted an option to purchase 7,860,000 shares of the Issuer's common stock pursuant to the Amended and Restated 2021 Plan. The option will vest as to 25% of the shares covered by the option on the one-year anniversary of the Grant Date and in quarterly installments thereafter over the next three years.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 07, 2025 Filed Oct 9, 2025 20:15 UTC | USBC, Inc. USBC · Entity 6370 | GrantOption to Purchase Common Stock · Derivative | 7,860,000 | $0.00 Strike: $1.10 | $0.00 |
DisclosureSEC source: 0001161697-25-000358 · form4.xml · derivative · entry 3 Chapman Kirk · CIK 0002080978 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000,000 Underlying: Common Stock · 7,860,000 shares Expires 2035-10-07 F3 · security: On October 7, 2025, the Reporting Person was granted an option to purchase 7,860,000 shares of the Issuer's common stock pursuant to the Amended and Restated 2021 Plan. The option will vest as to 25% of the shares covered by the option on the one-year anniversary of the Grant Date and in quarterly installments thereafter over the next three years. F3 · derivative.exercise_date: On October 7, 2025, the Reporting Person was granted an option to purchase 7,860,000 shares of the Issuer's common stock pursuant to the Amended and Restated 2021 Plan. The option will vest as to 25% of the shares covered by the option on the one-year anniversary of the Grant Date and in quarterly installments thereafter over the next three years. Read SEC document |
| October 07, 2025 Filed Oct 9, 2025 20:15 UTC | USBC, Inc. USBC · Entity 6370 | GrantOption to Purchase Common Stock · Derivative | 7,140,000 | $0.00 Strike: $1.10 | $0.00 |
DisclosureSEC source: 0001161697-25-000358 · form4.xml · derivative · entry 2 Chapman Kirk · CIK 0002080978 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,140,000 Underlying: Common Stock · 7,140,000 shares Expires 2035-10-07 F2 · security: On October 7, 2025, in accordance with the terms of the Amended and Restated 2021 Plan, the Board of Directors the Company approved a repricing of outstanding stock options granted on August 6, 2025. The exercise price of each repriced option was reduced from $2.45 to $1.10 per share. F2 · derivative.exercise_date: On October 7, 2025, in accordance with the terms of the Amended and Restated 2021 Plan, the Board of Directors the Company approved a repricing of outstanding stock options granted on August 6, 2025. The exercise price of each repriced option was reduced from $2.45 to $1.10 per share. Read SEC document |
| October 07, 2025 Filed Oct 9, 2025 20:15 UTC | USBC, Inc. USBC · Entity 6370 | Disposition to issuerOption to Purchase Common Stock · Derivative | 7,140,000 | $0.00 Strike: $2.45 | $0.00 |
DisclosureSEC source: 0001161697-25-000358 · form4.xml · derivative · entry 1 Chapman Kirk · CIK 0002080978 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,140,000 shares Expires 2035-08-06 F1 · security: The transactions reported involved the repricing of outstanding stock options to purchase 7,140,000 shares of common stock of USBC, Inc. (the "Company") pursuant to the Amended and Restated USBC, Inc. 2021 Equity Incentive Plan (the "Amended and Restated 2021 Plan"), initially granted on August 6, 2025 (the "Grant Date"). The option will vest as to 25% of the shares covered by the option on the one-year anniversary of the Grant Date and in quarterly installments thereafter over the next three years. F1 · derivative.exercise_date: The transactions reported involved the repricing of outstanding stock options to purchase 7,140,000 shares of common stock of USBC, Inc. (the "Company") pursuant to the Amended and Restated USBC, Inc. 2021 Equity Incentive Plan (the "Amended and Restated 2021 Plan"), initially granted on August 6, 2025 (the "Grant Date"). The option will vest as to 25% of the shares covered by the option on the one-year anniversary of the Grant Date and in quarterly installments thereafter over the next three years. Read SEC document |
| August 06, 2025 Filed Aug 16, 2025 01:02 UTC | USBC, Inc. USBC · Entity 6370 | GrantOption to Purchase Common Stock · Derivative | 7,140,000 | $0.00 Strike: $2.45 | $0.00 |
DisclosureSEC source: 0001161697-25-000277 · form4.xml · derivative · entry 1 Chapman Kirk · CIK 0002080978 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,140,000 Underlying: Common Stock · 7,140,000 shares Expires 2035-08-06 F1 · security: On August 6, 2025 (the "Grant Date"), the Reporting Person was granted an option to purchase 7,140,000 shares of the Issuer's common stock pursuant to the Issuer's 2021 Equity Incentive Plan. The option will vest as to 25% of the shares covered by the option on the one-year anniversary of the Grant Date and in quarterly installments thereafter over the next three years. F1 · kind: On August 6, 2025 (the "Grant Date"), the Reporting Person was granted an option to purchase 7,140,000 shares of the Issuer's common stock pursuant to the Issuer's 2021 Equity Incentive Plan. The option will vest as to 25% of the shares covered by the option on the one-year anniversary of the Grant Date and in quarterly installments thereafter over the next three years. F1 · derivative.exercise_date: On August 6, 2025 (the "Grant Date"), the Reporting Person was granted an option to purchase 7,140,000 shares of the Issuer's common stock pursuant to the Issuer's 2021 Equity Incentive Plan. The option will vest as to 25% of the shares covered by the option on the one-year anniversary of the Grant Date and in quarterly installments thereafter over the next three years. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.